Neoplasms

All Conditions

Respiratory Tract (Lung and Bronchial) Diseases

Symptoms and General Pathology

Carcinoma

Respiratory Aspiration

Carcinogenesis

Carcinoma, Bronchogenic

Metaplasia

Bronchial Neoplasms

Lung Neoplasms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Anti-Allergic Agents

Anti-Inflammatory Agents

Dermatologic Agents

Respiratory System Agents

All Drugs and Chemicals

Fluticasone

Xhance

Bronchodilator Agents

Anti-Asthmatic Agents

Fluticasone propionate

Egbert F Smit, MD PHD

The purpose of this study is to assess the efficacy of fluticasone on the development of lung cancer in smokers

Bronchial epithelium exposed to cigarette smoke undergoes a series of histological changes that may ultimately lead to invasive cancer. In rats exposed to cigarette smoke inhaled corticosteroids reduce the number of lung tumors. The purpose of this study is to assess the efficacy of fluticasone on premalignant lesions in volunteers with a smoking history of \>10 pack-years and patients cured of head and neck cancer or lung cancer. Participants are screened for premalignant lesions by bronchoscopy and if these are present randomised to receive a powder inhalation device containing either fluticasone 500 μg or a placebo. After 6 months, biopsies are taken from the same locations. Efficacy of treatment is assessed by reversal of metaplasia/dysplasia; secondary end-points are reversal of increased p53 immunoreactivity and hTERT expression.

Randomized Trial of Fluticasone in Bronchial Premalignancy

The Influence of Fluticasone Inhalation on Intermediate Markers of Carcinogenesis in the Bronchial Epithelium of a High Risk Population : A Double Blind Placebo-Controlled Randomised Phase II Study

GlaxoSmithKline

The Netherlands Cancer Institute

Amsterdam UMC, location VUmc

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Randomized Trial of Fluticasone in Bronchial Premalignancy	NCT00407264	Bronchogenic Ca...	Fluticasone pro...	18 Years -	Amsterdam UMC, location VUmc
Randomized Trial of Fluticasone in Bronchial Premalignancy	NCT00407264	Bronchogenic Ca...	Fluticasone pro...	18 Years -	Amsterdam UMC, location VUmc

Spots Global Cancer Trial Database for bronchial squamous metaplasia